Search research articles
Contact Us
Filters
Showing results (401-410 of 634) with videos related to
Page
of 64
Sort By:
Journal of the Royal Society of Medicine
|
November 2, 2010
Evidence-based mechanistic reasoning
Jeremy Howick, Paul Glasziou, Jeffrey K Aronson
Clinical Science (London, England : 1979)
|
October 24, 1997
Evidence for an R(+)-[(dihydroindenyl)oxy]alkanoic acid-sensitive K+/Cl- co-transporter in human platelets and its interaction with the Na+/K+/2Cl- co-transporter
H A de Silva, J K Aronson
British Journal of Clinical Pharmacology
|
April 20, 2004
A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone
Yoon K Loke, Sheena Derry, Jeffrey K Aronson
Drug Safety
|
February 17, 2016
Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP)
Manfred Hauben, Jeffrey K Aronson, Robin E Ferner
BMJ (Clinical Research Ed.)
|
July 26, 2018
Prescribing biosimilars
Jeffrey K Aronson, Ben Goldacre, Robin E Ferner
Drug Safety
|
February 25, 2009
A strategy for regulatory action when new adverse effects of a licensed product emerge
Jeffrey K Aronson, Deirdre Price, Robin E Ferner
Drug Safety
|
January 26, 2012
Paradoxical and bidirectional drug effects
Silas W Smith, Manfred Hauben, Jeffrey K Aronson
BMC Medical Research Methodology
|
October 10, 2001
Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
S Derry, Y K Loke, J K Aronson
Fundamental & Clinical Pharmacology
|
March 21, 2002
Adverse drug reactions: keeping up to date
Jeffrey K Aronson, Sheena Derry, Yoon K Loke
BMJ Evidence-Based Medicine
|
December 2, 2020
Coroners' concerns to prevent harms: a series of coroners' case reports to serve patient safety and educate the public, clinicians and policy-makers
Georgia C Richards, Jeffrey K Aronson, Carl Heneghan
Page
of 64
Search research articles
Search
Showing results (401-410 of 634) with videos related to
Sort By:
Page
of 64
Journal of the Royal Society of Medicine
|
November 2, 2010
Evidence-based mechanistic reasoning
Jeremy Howick, Paul Glasziou, Jeffrey K Aronson
Clinical Science (London, England : 1979)
|
October 24, 1997
Evidence for an R(+)-[(dihydroindenyl)oxy]alkanoic acid-sensitive K+/Cl- co-transporter in human platelets and its interaction with the Na+/K+/2Cl- co-transporter
H A de Silva, J K Aronson
British Journal of Clinical Pharmacology
|
April 20, 2004
A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone
Yoon K Loke, Sheena Derry, Jeffrey K Aronson
Drug Safety
|
February 17, 2016
Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP)
Manfred Hauben, Jeffrey K Aronson, Robin E Ferner
BMJ (Clinical Research Ed.)
|
July 26, 2018
Prescribing biosimilars
Jeffrey K Aronson, Ben Goldacre, Robin E Ferner
Drug Safety
|
February 25, 2009
A strategy for regulatory action when new adverse effects of a licensed product emerge
Jeffrey K Aronson, Deirdre Price, Robin E Ferner
Drug Safety
|
January 26, 2012
Paradoxical and bidirectional drug effects
Silas W Smith, Manfred Hauben, Jeffrey K Aronson
BMC Medical Research Methodology
|
October 10, 2001
Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
S Derry, Y K Loke, J K Aronson
Fundamental & Clinical Pharmacology
|
March 21, 2002
Adverse drug reactions: keeping up to date
Jeffrey K Aronson, Sheena Derry, Yoon K Loke
BMJ Evidence-Based Medicine
|
December 2, 2020
Coroners' concerns to prevent harms: a series of coroners' case reports to serve patient safety and educate the public, clinicians and policy-makers
Georgia C Richards, Jeffrey K Aronson, Carl Heneghan
Page
of 64